Accelrys to Merge with Symyx to Create 'Holistic' Offering via Complementary Products

Max Carnecchia, CEO of Accelrys, said this week in a conference call to discuss the transaction that the merger will create a scientific informatics company with a more "holistic" offering than either firm is able to offer now.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.